Biomarkers for the prognosis and high-grade glioma clinical outcome

0 avis

Biomarkers for the prognosis and high-grade glioma clinical outcome

Archive ouverte

Mosser, Jean | Tayrac, Marie De | Aubry, Marc

Edité par CCSD -

The present invention relates to the identification and use of biomarkers with clinical relevance to high grade gliomas (HGGs). In particular, the invention provides the identity of four genes, CHAF1B, PDLIM4, EDNRB and HJURP, whose expression, at the transcriptome and proteome levels, is correlated with HGG grading and clinical survival outcome. Methods and kits are provided for using these biomarkers in the prognostication of HGGs, and in the selection and/or monitoring of treatment regimens.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Combining evidence, biomedical literature and statistical dependence: new insights for functional annotation of gene sets.

Archive ouverte | Aubry, Marc | CCSD

18 p.. International audience. BACKGROUND: Large-scale genomic studies based on transcriptome technologies provide clusters of genes that need to be functionally annotated. The Gene Ontology (GO) implements a contro...

A 4-gene signature associated with clinical outcome in high-grade gliomas.

Archive ouverte | de Tayrac, Marie | CCSD

International audience. PURPOSE: Gene expression studies provide molecular insights improving the classification of patients with high-grade gliomas. We have developed a risk estimation strategy based on a combined ...

Differential expression of genes related to HFE and iron status in mouse duodenal epithelium.

Archive ouverte | Abgueguen, Emmanuelle | CCSD

International audience. Iron absorption, distribution, use, and storage are thought to be tightly regulated since altered iron stores may lead to cellular damage and disease. HFE, the hereditary hemochromatosis gene...

Chargement des enrichissements...

Syracuse